RJV001 Study in Adults Receiving Abdominoplasty

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 16, 2021

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions
Submental Fat (SMF)Double Chin
Interventions
DRUG

RJV001

Subcutaneous injection in the abdomen

DRUG

Placebo

The placebo formulation has the same shape, color, and qualitative composition as the RJV001 freeze dried powder, with the exception that RJV001 drug substance has been removed. For each cohort group, a placebo will be injected in a single site in the same area as the treatment.

Trial Locations (1)

85053

Study site: Arizona Research Center, Phoenix

All Listed Sponsors
lead

Rejuven Dermaceutical Co., Ltd.

INDUSTRY